melan-a
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2004 (NCT00559026)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- melan-a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00559026 | Phase 1 | Sep 1, 2004 | ISTITUTO REGINA ELENA, Istituto Superiore di Sanità, University of Rome Tor Vergata |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ISTITUTO REGINA ELENA | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Istituto Superiore di Sanità | Academic/Hospital | 1 | 1 | 1 | 2004 |
| University of Rome Tor Vergata | Academic/Hospital | 1 | 0 | 1 | 2004 |
3 organizations
Page 1 / 1